Document is current
Any future updates will be listed below
-
Authors
Cai, Zhaoxiang http://orcid.org/0000-0003-3809-0817
Apolinário, Sofia http://orcid.org/0009-0005-6076-2108
Baião, Ana R.
Pacini, Clare http://orcid.org/0000-0001-7791-0940
Sousa, Miguel D.
Vinga, Susana http://orcid.org/0000-0002-1954-5487
Reddel, Roger R. http://orcid.org/0000-0002-6302-6107
Robinson, Phillip J. http://orcid.org/0000-0002-7878-0313
Garnett, Mathew J. http://orcid.org/0000-0002-2618-4237
Zhong, Qing http://orcid.org/0000-0002-5340-301X
Gonçalves, Emanuel http://orcid.org/0000-0002-9967-5205
- License Information
-
More Information
Article History
Received: 21 December 2023
Accepted: 18 November 2024
First Online: 29 November 2024
Competing interests
: AstraZeneca, GlaxoSmithKline, and Astex Pharmaceuticals have awarded M.J.G. research grants and M.J.G. is founder and advisor at Mosaic Therapeutics. All other authors declare no competing interests.
